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Abstract: Objective: To analyze and explore the clinical observation of coronary artery disease with coronary heart
disease and coronary heart disease (CHD) undergoing coronary artery bypass grafting. Methods: From December 2015
to December 2016, 80 patients with coronary heart disease and heart valve were randomly divided into two groups:
observation group and control group (40 cases). The observation group was treated with coronary artery bypass grafting
combined with simultaneous heart valve replacement. The control group was treated with coronary stent implantation
and non-synchronous valve replacement. The improvement of postoperative cardiac function, postoperative
hospitalization, adverse events and bridge patency were compared between the two groups. Results: The improvement
of cardiac function and the incidence of adverse events were significantly better in the observation group than in the
control group (P <0.05). The time of hospitalization and the time of ventilator were significantly shorter than those of
the control group (P <0.05). The patency rate of the bridge was significantly higher than that of the control group (P
<0.05). Conclusion: Coronary artery bypass grafting combined with heart valve replacement in patients with coronary
heart disease complicated with valvular heart disease can achieve significant curative effect, which is more ideal and
safer than coronary artery bypass surgery combined with non-synchronous valve replacement. The
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Introduction
According to the clinical reports show that in recent years the number of aging population in China was significantly
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climbing, followed by the incidence of coronary atherosclerotic heart disease with heart valve disease is also increasing
year by year in China, coronary heart disease incidence of mitral or aortic valve disease is about 15%. Such diseases are
mainly in elderly and patients with valvular heart disease, the patient is older and sick longer and accompanied by other
medical diseases, the condition is relatively complex. At present, patients with coronary heart disease and coronary
heart disease underwent coronary artery bypass grafting combined with heart valve surgery, but because of this
operation is longer, easy to induce various complications after surgery, thus increasing the operation difficulty and risk,
the corresponding clinical reports and research is clearly lacking. However, such surgery can be completed once the
treatment, reduce the second operation and reoperation rate, can significantly improve the long-term survival rate of
patients. In our hospital, some patients with coronary heart disease with valvular heart disease in the course of treatment
of coronary artery bypass grafting in the same period of heart valve replacement surgery, and achieved some research
results. The results are summarized as follows.
1. Materials and methods
1.1 General information
80 patients with coronary heart disease complicated with heart valve were enrolled in our hospital from December 2015
to December 2016. All patients were randomly divided into two groups: 40 patients in each group. There were 21 males
and 19 females in the observation group. The age was 45 to 86 years (mean, 64.9 ± 5.7 years). The cardiac function
grade: grade Ⅱ, grade Ⅲ, grade 23, grade 7. There were 22 males and 18 females in the control group. The age was 46
to 85 years (mean, 65.9 ± 6.2 years). The cardiac function grade was 11 cases with grade Ⅱ, 25 cases of grade Ⅲ and 4
cases of grade Ⅳ. Statistical analysis of the two groups of patients with gender, age, cardiac function classification and
other general data difference was not statistically significant (P> 0.05), comparable.
1.2 Selection criteria
1) Inclusion criteria: all patients were diagnosed with coronary heart disease with valvular heart disease by ultrasound,
coronary angiography and pathology; dynamic electrocardiogram showed left and right bundle branch dysfunction, left
ventricular hypertrophy, atrial fibrillation; cardiac function classification in the Ⅱ ~ Ⅳ level; combined with diabetes,
hypertension, liver and kidney dysfunction and other diseases; clinical data is complete; better awareness, with the
investigation; signed on this study informed consent. 2) Exclusion criteria: suffering from mental illness, lack of
autonomy; there are contraindications for surgery; clinical data incomplete; patients and their families did not sign
informed consent or can not effectively cooperate with the study.
1.3 Method
In the trial group, patients underwent coronary artery bypass grafting for heart valve replacement. The patients were
treated with general anesthesia and underwent cardiopulmonary bypass. After successful operation, the incision was
performed from the sternum and the heart was exposed. The left internal mammary artery and the left internal
mammary artery large saphenous vein free to prepare for surgery. In the aorta and superior vena cava, the inferior vena
cava, respectively, intubation to form an extracorporeal circulation. In the course of the application of cold blood
cardioplegia intermittent irrigation and coronal venous sinus retrograde perfusion combined with the method of
myocardial protection. After the heart to stop the pulse after the first bridge to the distal vascular anastomosis, and then
to implement the heart surgery. After the heart is restored to orthosis, the mitral and aortic valve plasty is performed or
replaced. The valve is selected for artificial mechanical valve. The mitral valve was replaced by 2-0 Prolene line and the
aortic valve was fixed by intermittent stitching. The time of aorta and cardiopulmonary bypass was controlled at (98.18
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± 28.65) min, (163.15 ± 37.53) min. In the control group, patients underwent coronary artery bypass grafting with heart
valve replacement. The patients underwent coronary artery bypass grafting, while the time of heart valve operation was
controlled at (216.74 ± 41.35) d. All patients in the group were routinely subjected to hemodynamics and were treated
with positive inotropic and vasoactive drugs, reduced pulmonary arterial pressure, expanded coronary artery and
underlying disease drug therapy.
1.4 Observe indicators
Two groups of patients were followed up for 1 year. (1) Cardiac function improvement index: cardiothoracic ratio,
LVEF (left echocardiography fraction), LVD (A-P) (left ventricular end diastolic diameter) (2) Postoperative situation:
ICU (severe intensive care ward) monitoring time, the level of heart failure, LVEF (left ventricular ejection fraction),
LVD (AP) (left ventricular end diastolic diameter) Ventilator application time, length of stay; (3) Adverse events: flap
valve leakage, permanent pacemaker implantation, death and so on. (4) Vascular bridge patency: vascular stenosis
diameter <50% or no stenosis for the smooth; vascular diameter obstruction 50% to 99% of the stenosis; complete
occlusion.
1.5 Statistical methods
All data were analyzed by SPSS 18.0 statistical software. (X ± s) that measurement data, with t test, count data with χ2
test, compared with the group [n (%)] said. P <0.05 for the difference was statistically significant.
2. Results
2.1 Heart function improvement
The improvement of cardiac function in the observation group was significantly better than that in the control group at 1
week and 1 year after operation (P <0.05). See Table 1.
Table 1 Comparison of two groups of cardiac function improvement (x ± s)








t 7.044 3.571 6.041








t 6.829 3.263 6.083
P ＜0.05 ＜0.05 ＜0.05
2.2 Postoperative situation
The time of ICU monitoring, hospitalization and ventilator were significantly shorter in the observation group than in
the control group (P <0.05). See Table 2.
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Table 2 Comparison of two groups after surgery (x ± s)








Control group 40 11.65±2.53 26.35±5.24 115.37±22.42
Observational
group
40 5.13±1.24 12.87±2.46 62.83±13.41
t 14.636 14.728 12.749
p ＜0.05 ＜0.05 ＜0.05
2.3 Comparison of two groups of adverse events
The incidence of pericardial leakage and the mortality rate were significantly lower than those of the control group (P
<0.05). See Table 3.
Table 3




Control group 40 9（22.50） 11（27.5） 10（25.00）
Observational
group
40 2（5.00） 6（15.00） 3（7.50）
X2 5.165 1.867 4.501
P ＜0.05 ＜0.05 ＜0.05
2.4 Comparison of vascular patency between two groups
The patency rate of the bridge was 80.00% (32/40) and 95.00% (38/40) in the observation group. The patency rate of
the bridge was significantly lower than that of the observation group (χ2 = 4.114, P <0.05).
3. Discussion
Coronary heart disease and valvular heart disease are common clinical cardiovascular disease, coronary heart disease is
caused by coronary atherosclerosis stenosis, obstruction, myocardial ischemia caused by hypoxic necrosis of heart
disease; heart valve disease refers to the aorta flap, mitral valve and other valves due to degenerative changes,
rheumatic fever, mucous degeneration, ischemic necrosis and other effects of blood flow, leading to cardiac dysfunction,
and ultimately cause valvular disease. Coronary heart disease with valvular heart disease is common in myocardial
infarction after the occurrence of valvular ischemic degeneration in patients with a combination of the two can
significantly improve the risk of disease, the safety of patients poses a serious threat.
Coronary atherosclerotic heart disease (coronary heart disease) with heart valve disease patients, surgical treatment
required at the same time coronary artery bypass grafting (CABG) and heart valve surgery, due to poor preoperative
cardiac function, surgical operation complex and long operative time, making the risk of surgery significantly higher
than the line of simple CABG or simple heart valve surgery. According to foreign literature, the early mortality rate of
such surgery was 7% -24%.
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Domestic literature reported that 12.68% of rheumatic heart disease patients with coronary heart disease. Patients before
surgery, comprehensive and detailed diagnosis and treatment is particularly important, not only determines the surgical
operation, but also determines the long-term prognosis after surgery. In general, patients with rheumatic valvular disease,
if the age of> 50 years old, previous angina or related medical history, ECG examination of myocardial ischemia (such
as changes in ST segment) or other coronary heart disease risk factors (such as high Blood pressure, diabetes,
hyperlipidemia, smoking, etc.), to meet one of the above factors in patients with preoperative routine CAG should be
checked to understand whether the merger of coronary artery lesions and lesions of the specific circumstances,
according to the development of better surgical program.
Complete revascularization is an important guarantee for successful surgery. DiSesa et al. reported an early death rate of
only 6.3% in 85 patients with complete revascularization of CABG + MVR myocardium, compared with 23.8% in 21
patients with incomplete CABG + MVR myocardial revascularization. Different patients, appropriate surgical
techniques and artificial blood vessels, to ensure smooth vascular bridge, complete revascularization of myocardium, as
much as possible to restore the blood supply to the heart, improve the impact of hemodynamics. To correct the correct
operation of the anastomosis of the coronary artery, the anastomosis position is accurate, and the time of occlusion and
extracorporeal circulation is shortened as far as possible under the premise of convenience, fastness and simplicity.
Coronary heart disease with valvular heart disease patients in the course of treatment of coronary artery bypass grafting
simultaneous treatment of heart valve replacement, due to poor preoperative cardiac function, surgical operation process
is more complex, intraoperative long time and other factors. Its surgical risk and simple coronary artery bypass grafting
and simple heart valve replacement compared to significantly increased. Coronary heart disease caused by myocardial
ischemia can cause valvular tendon ring and papillary muscle dysfunction, induced valvular disease. Coronary heart
disease at the same time will reduce the patient's myocardial contractility, change the internal structure and function of
the ventricle, and further aggravate the patient's condition. Current clinical studies have shown that patients with
coronary artery disease associated with valvular heart disease may be treated with coronary artery bypass grafting for
simultaneous cardiac valve replacement. When patients with coronary artery disease and heart valve disease coexist at
the same time, regardless of whether the presence of myocardial insufficiency in patients with performance, this time
should be treated on coronary artery disease, and nearly half of patients in the heart valve surgery at the same time need
to be coronary artery Road transplantation. This will not only reduce the risk of secondary surgery, but also reduce the
repeated surgery to patients with trauma and pain, reduce treatment time, increase the patient's perioperative cardiac
function recovery. But the clinical lack of a large number of coronary artery disease with heart valve disease with the
clinical basis of surgery, so the design of the study. The success of the surgery depends on whether the intraoperative
myocardial protection is in place.
The protective measures taken during the course of the study will help to reduce pulmonary edema and protect the
postoperative cardiac function, and should be based on the patient's pathophysiology according to the implementation of
targeted treatment measures, which reduce the mortality rate and the incidence of complications is of great significance,
(P <0.05). In the experimental group, the patients' postoperative cardiac function indexes and the control group were
significantly higher than those in the control group (P <0.05), and the difference between the two groups was
statistically significant (P <0.05) (P <0.05). The difference between the two groups was statistically significant (P
<0.05). This shows that the clinical efficacy of surgery over the same period more significant, especially to improve
cardiac function, reduce postoperative mortality and so on.
In summary, coronary artery bypass grafting combined with heart valve replacement in the treatment of coronary heart
disease with valvular heart disease is feasible and safe, can effectively improve the patient's heart function, and shorten
the hospital stay. But the perioperative period must take appropriate symptomatic treatment measures to maximize the
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protection of surgical safety.
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